<DOC>
	<DOCNO>NCT02028429</DOCNO>
	<brief_summary>The study conduct evaluate efficacy Sildenafil ( 5-phosphodiesterase inhibitor ) mean improve cognitive impairment encounter patient minimal hepatic encephalopathy ( MHE ) propose different study . This study would also assess role improvement cognition mean improvement quality life.The patient receive Sildenafil treatment 4 week . This study may prove provide important therapeutic strategy cognition impairment patient MHE .</brief_summary>
	<brief_title>Efficacy Sildenafil Improvement Cognition Quality Life Patients With Cirrhosis Liver . A Proof Concept Study .</brief_title>
	<detailed_description>Primary Aim 1 . To study proof concept improvement impairment cognition assess PHES ( psychometric hepatic encephalopathy score ) patient MHE mean pharmacological intervention Sildenafil ( phosphodiesterase ( PDE ) -5 inhibitor ) treatment . 2 . To study impact treatment Sildenafil administration improvement health-related quality-of-life patient assessed Sickness impact profile ( SIP ) treatment . Secondary Aim 1 . To study impact treatment Sildenafil CTP MELD score treatment . 2 . To study impact treatment Sildenafil blood ammonia Interleukin-6 level treatment . Study Population : The study population comprise male adult ( age 18-70 year ) cirrhosis liver . Patients cirrhosis liver divide two group - MHE without MHE ( NMHE ) base test result PHES , i.e. , abnormal ( MHE group ) normal ( NMHE group ) . Inclusion Criteria : - Male patient age 18-70 year diagnose cirrhosis liver Liver Clinic Department Hepatology , Postgraduate Institute Medical Education &amp; Research ( PGIMER ) , Chandigarh mean clinical , biochemical ultrasonographical/CT liver biopsy . - MHE define PHES ≤-5 normal Mini-Mental State Examination ( MMSE ) score ≥24 . Exclusion Criteria : - Patients unable give inform consent . - H/O alcohol intake last 12 week . - Significant comorbid illness heart disease , respiratory disease , renal failure . - Any neurological disease Alzheimer disease , Parkinson 's disease , stroke , non- hepatic metabolic encephalopathy 's . - Any anatomical deformity disease penis Peyronie 's disease . - Patients psychiatric illness take treatment antidepressant , sedative neuroleptic . - Patients start take alcohol study period exclude . - Patients take vasodilator nitrate . - Hepatocellular carcinoma . - Recent history upper GI bleed last 6 week . - Active ongoing infection . - Electrolyte abnormality precipitate MHE . - Color vision abnormality .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>• Male patient age 1870 year diagnose cirrhosis liver Liver Clinic Department Hepatology , PGIMER Chandigarh mean clinical , biochemical ultrasonographical/CT liver biopsy . MHE define PHES ≤5 normal MMSE score ≥24 . Patients unable give inform consent . H/O alcohol intake last 12 week . Significant comorbid illness heart disease , respiratory disease , renal failure . Any neurological disease Alzheimer disease , Parkinson 's disease , stroke , non hepatic metabolic encephalopathy 's . Any anatomical deformity disease penis Peyronie 's disease . Patients psychiatric illness take treatment antidepressant , sedative neuroleptic . Patients start take alcohol study period exclude . Patients take vasodilator nitrate . Hepatocellular carcinoma . Recent history upper GI bleed last 6 week . Active ongoing infection . Electrolyte abnormality precipitate MHE . Color vision abnormality .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Minimal Hepatic Encephalopathy ( MHE )</keyword>
	<keyword>Psychometric Hepatic Encephalopathy Score ( PHES )</keyword>
	<keyword>Sickness Impact Profile ( SIP )</keyword>
	<keyword>Model End-stage Liver Disease ( MELD )</keyword>
	<keyword>Child-Turcotte-Pugh score ( CTP )</keyword>
</DOC>